SPIKEVAX is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Catalent Indiana, Llc. The primary component is Elasomeran.
| Product ID | 61434-043_05780332-1acb-4683-9849-d0cf5faa7a67 | 
| NDC | 61434-043 | 
| Product Type | Vaccine | 
| Proprietary Name | SPIKEVAX | 
| Generic Name | Covid-19 Vaccine, Mrna | 
| Dosage Form | Injection, Suspension | 
| Route of Administration | INTRAMUSCULAR | 
| Marketing Start Date | 2022-04-01 | 
| Marketing Category | BLA / | 
| Application Number | BLA125752 | 
| Labeler Name | Catalent Indiana, LLC | 
| Substance Name | ELASOMERAN | 
| Active Ingredient Strength | 0 mg/.5mL | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2022-04-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 61434-043 | SPIKEVAX | COVID-19 Vaccine, mRNA | 
| 80777-100 | Spikevax | COVID-19 Vaccine, mRNA | 
| 0069-2025 | Comirnaty | COVID-19 Vaccine, mRNA | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  SPIKEVAX  97037862  not registered Live/Pending | ModernaTx, Inc. 2021-09-21 | 
|  SPIKEVAX  90247367  not registered Live/Pending | ModernaTx, Inc. 2020-10-11 |